when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

pharmadog news

Browse

1,777 stories matching this filter · ← front page

★ save view ↓export CSV

rangeto

sort

recent oldest source alpha

source

STAT829 Endpoints632 BioPharma Dive241 onclive165 Fierce Biotech93 BioSpace91 raps37 globenewswire health

therapy area

all Oncology4989 Rare Disease831 Hematology761 Cardiology717 Immunology715 Psychiatry & CNS579 Pulmonology

Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) Issues Voluntary Nationwide Recall of Cetirizine Hydrochloride Tablets USP 5 mg Due to Potential Cross Contamination with Ranitidine
FOR IMMEDIATE RELEASE – July 18th, 2026 – Panoli, Gujarat, Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) is voluntarily recalling four lots of Cetirizine Hyd…
fda medwatch · 11d ago↗ source
Recon: BMS to construct AI supercomputer with Nividia; Tempus to acquire cancer diagnostic maker Personalis for $1.5B
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
raps · 11d ago↗ source
Asia-Pacific Roundup: TGA seeks feedback on Australian regulations for digital mental health tools

page 14 of 72

28

570

Endocrinology & Metabolism288

Ophthalmology254

Infectious Disease247

Australia’s Therapeutic Goods Administration (TGA) is holding a consultation to inform changes to the regulatory framework for digital mental health tools (DMHTs).

raps · 11d ago↗ source

Study: China outpaces the US in cancer approvals, lags behind on first approvals

While China's National Medical Products Administration (NMPA) approved more oncology drugs compared to the US Food and Drug Administration (FDA) from 2020 to 2025, the US regulator approved more fi…

raps · 11d ago↗ source

MHRA touts uptick in approvals in 2025-2026 annual report

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) touted its achievements over the last year its 2025-2026 annual report to Parliament, which includes approving more new drugs tha…

raps · 11d ago↗ source

Latigo preps IPO to fund non-opioid pain drug rival to Vertex’s Journax

Latigo Biotherapeutics is preparing to go public in order to bankroll the development of its clinical-stage pipeline of non-opioid pain management drugs.

Fierce Biotech · 11d ago↗ source

Geopolitics ‘chills’ British biotech IPO plans, despite $2B in Q2 VC funds

Geopolitical uncertainty has continued to “chill” IPO sentiment among British biotechs, an industry leader has told Fierce, even as the sector saw second-quarter venture capital funding reach a fiv…

Fierce Biotech · 12d ago↗ source

Abbott hit by cyberattack on cancer diagnostics, LabCentral portal businesses

Abbott has been struck by several cyberattacks which targeted the medtech giant’s cancer diagnostics and LabCentral businesses.

Fierce Biotech · 12d ago↗ source

Opinion: Beware the unintended consequences of testosterone screening for military servicemembers

“I fear that the widespread rollout of testosterone screening may lead to some surprising and unintended consequences,” writes a urologist who studies testosterone.

STAT · 12d ago↗ source

Biogen’s mixed Alzheimer’s data; Two new startups launch; and more

Welcome back to another edition of Endpoints Weekly! We hope you all have been staying safe indoors as the Canadian wildfires blanketed much of the US Northeast this week. Hopefully things calm dow…

Endpoints · 13d ago↗ source

‘A rising tide scenario’: Why other Big Pharmas could follow Lilly into psychedelics

After Eli Lilly dived into the psychedelics space with a $2.8 billion upfront acquisition of AtaiBeckley last week, industry experts told Fierce that the deal would give the space added momentum.

Fierce Biotech · 13d ago↗ source

Opinion: STAT readers on the value of primary care, obesity as a disease, and more

“The real opportunity is to move beyond policies and narratives that pit specialties against one another,” presidents of the AAFP, ACP, and AAP write.

STAT · 13d ago↗ source

Opinion: What the 20th-century war on smog tells us about today’s wildfire smoke

The evolution of air pollution policy shows how to respond to the dangerous haze caused by Canadian wildfires, experts write in opinion piece.

STAT · 13d ago↗ source

Midsized biotechs press White House to drop CMS pricing rules

A number of midsized biotech companies have met with White House and HHS officials in the last week, presenting their case for why two pending CMS pricing models could hinder their business and sho…

Endpoints · 13d ago↗ source

Celcuity got its cancer drug approved. Then its stock dipped

The FDA’s approval for Celcuity’s cancer drug Revtorpyk on Tuesday was widely anticipated. What Wall Street didn’t expect was that the drug could take until the end of the quarter to launch. ...

Endpoints · 13d ago↗ source

Quitting smoking is hard. A Medicare change may push doctors to give more help

Physicians who offer counseling on quitting cigarettes and alcohol during patient visits would get a 19% increase in reimbursement under a proposed Medicare change.

STAT · 13d ago↗ source

Lettuce at Taco Bell in five states confirmed as a source of diarrhea-causing parasite

Health officials have identified lettuce from Mexico served at Taco Bell locations across five U.S. states as a source of the outbreak of diarrhea-causing parasite cyclospora.

STAT · 13d ago↗ source

GSK plans large study to see if shingles vaccine can prevent dementia

LONDON — Over the past several years, data scientists searching through national health records have noticed something surprising about people who had been vaccinated for shingles: They were less l…

Endpoints · 13d ago↗ source

Dimerix buys a kidney injury drug; Arpeggio appears to be winding down

Plus, news about Takeda, Novartis and Regenxbio. 🤝 Mission sells kidney injury drug to Dimerix: Dimerix will pay $5 million upfront for Mission’s Phase 2-ready candidate for acute kidney injury, k…

Endpoints · 13d ago↗ source

STAT+: The end for GSK’s chronic cough treatment

Sonothera's ultrasound gene therapy delivery, a new Alzheimer's drug controversy, and more biotech news from The Readout

STAT · 13d ago↗ source

Updated: BlossomHill and Latigo join flourishing IPO queue with cancer, pain drugs

Last summer, zero biotechs made it onto the public markets as the industry weathered a seven-month dry spell for initial share sales. This time around, it's a summer IPO party as six

Endpoints · 13d ago↗ source

STAT+: Up and down the ladder: The latest comings and goings

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

STAT · 13d ago↗ source

STAT+: Pharmalittle: We’re reading about rising drug shortages, GSK coughing up a trial loss, and more

The number of active medication shortages in the U.S. rose to 227 in the second quarter of 2026

STAT · 13d ago↗ source

BlossomHill eyes IPO as fertilizer to grow taller in crowded cancer fields

Another biotech is squeezing into the crowded IPO waiting room just in time for the weekend. BlossomHill Therapeutics, a San Diego-based oncology outfit focused on small molecules, has filed paperw…

Fierce Biotech · 13d ago↗ source

Who can access testosterone hormone medication in the U.S.?

Wildfire smoke health hazards, a new idea for treating Duchenne, and more health news from Morning Rounds

STAT · 13d ago↗ source